Testing effectiveness (Phase 2)Active Not RecruitingNCT02314169
What this trial is testing
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
Who this might be right for
Anal Canal Squamous Cell CarcinomaMetastatic Anal Canal CarcinomaStage IV Anal Cancer AJCC v8
National Cancer Institute (NCI) 143